Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

Sponsor
University at Buffalo
Study ID
NCT01299012
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Evaluating the use of Liraglutide in patients with Type 1 Diabetes.

Key Dates

Start date
Oct 31, 2010
Status verified
Feb 2017
Primary completion
Feb 28, 2013
Completion
Jun 30, 2013

Study Design

Enrollment
30 participants (actual)

Primary Outcome Measure

Improved Blood Glucose comtrol in Type 1 Diabetes Patients with Liraglutide [ Time Frame: 20 weeks ]

Related Studies